Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Part of paid clinical trials in Fort Smith, Arkansas.
- Sponsor
- Tempus AI
- Study ID
- NCT05234177
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Observation — OTHERNo intervention
Study Details
The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.
Key Dates
- Start date
- Jun 21, 2022
- Status verified
- May 2025
- Primary completion
- Feb 28, 2027
- Completion
- Feb 28, 2029
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Participants with stage I-IV colorectal cancer (CRC)This protocol will include participants with stage I-IV CRC who are scheduled to undergo or have undergone a surgical resection with curative intent.
Primary Outcome Measure
Recurrence-Free Survival [ Time Frame: 2 years ]
Central Contacts
- CRC Surveillance Study(833) 514-4187
Locations (20)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mercy Clinic Oncology - Fort Smith | Fort Smith | Arkansas | 72903 | Billy Cater Aswanth Reddy, MD (PRINCIPAL_INVESTIGATOR) |
| MemorialCare | Fountain Valley | California | 92708 | Amol Rao, MD (PRINCIPAL_INVESTIGATOR) |
| The Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | Mark Goldstein, MD (PRINCIPAL_INVESTIGATOR) |
| Mercy Clinic Oncology and Hematology - Joplin | Joplin | Missouri | 64804 | Cynthia Meyer Samir Dalia, MD (PRINCIPAL_INVESTIGATOR) |
| Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center | Springfield | Missouri | 65804 | Jennifer Hylton Mohan Tummala, MD (PRINCIPAL_INVESTIGATOR) |
| Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center | St Louis | Missouri | 63141 | Emily Hoven Bethany Sleckman, MD (PRINCIPAL_INVESTIGATOR) |
| Mercy Clinic Oncology and Hematology - Sindelar Cancer Center | St Louis | Missouri | 63128 | Jessica Black Yifan Tu, MD (PRINCIPAL_INVESTIGATOR) |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Ryan Fields, MD (PRINCIPAL_INVESTIGATOR) |
| Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | Timothy Huyck, MD (PRINCIPAL_INVESTIGATOR) |
| Southeastern Medical Oncology Center | Goldsboro | North Carolina | 27543 | Samer Kasbari, MD (PRINCIPAL_INVESTIGATOR) |
| Aultman Hospital | Canton | Ohio | 44710 | Kristin Shine Adarsh Vennepureddy, MD (PRINCIPAL_INVESTIGATOR) |
| TriHealth Cancer Institute | Cincinnati | Ohio | 45220 | Benjamin Kuritzky, MD (PRINCIPAL_INVESTIGATOR) |
| Ohio State University | Columbus | Ohio | 43210 | Jennifer Moon Arjun Mittra, MD (PRINCIPAL_INVESTIGATOR) |
| OhioHealth Research Institute | Columbus | Ohio | 43214 | Arvinder Bhinder, MD (PRINCIPAL_INVESTIGATOR) |
| Toledo Clinic Cancer Center | Toledo | Ohio | 43623 | John Nemunaitis, MD (PRINCIPAL_INVESTIGATOR) |
| Mercy Clinic Oncology and Hematology - Coletta | Oklahoma City | Oklahoma | 73120 | Patricia Strubhar Carla Kurkjian, MD (PRINCIPAL_INVESTIGATOR) |
| Cancer Care Associates of York | York | Pennsylvania | 17403 | Chanh Huynh, MD (PRINCIPAL_INVESTIGATOR) |
| Utah Cancer Specialists | Salt Lake City | Utah | 84124 | Kyle Kitchen, Pharm-D (PRINCIPAL_INVESTIGATOR) |
| University of Washington / Fred Hutchinson Cancer Center | Seattle | Washington | 98109 | Bentina Marin Stacey Cohen, MD (PRINCIPAL_INVESTIGATOR) |
| ThedaCare Regional Cancer Center | Appleton | Wisconsin | 54911 | Matthias Weiss, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Fort Smith, AR
By condition
By specialty
By research site
Mercy Clinic Oncology - Fort Smith· Fort Smith, ARMemorialCare· Fountain Valley, CAThe Center for Cancer and Blood Disorders· Bethesda, MDMercy Clinic Oncology and Hematology - Joplin· Joplin, MOMercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center· Springfield, MOMercy Clinic Oncology and Hematology - David C. Pratt Cancer Center· St Louis, MO
Related Studies
- Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersRecruiting · University of Missouri-Columbia · Columbia, Missouri
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California